Publikačný výstup

Paclitaxel Treatment and Proprotein Convertase 1/3 (PC1/3) Knockdown in Macrophages is a Promising Antiglioma Strategy as Revealed by Proteomics and Cytotoxicity Studies : [Liečba paklitaxelom a vylučovanie PC1/3 v makrofágoch je sľubnou stratégiou antigliómu, ako sa ukázalo v štúdiách proteomiky a cytotoxicity]

Informácie o publikácii

Zápis:

DUHAMEL, Marie - ROSE, Mélanie - RODET, Franck - MURGOCI, Adriana - Natalia - ZOGRAFIDOU, Lea - RÉGNIER-VIGOUROUX, Anne - VANDEN ABEELE, Fabien - KOBEISSY, Firas - NATAF, Serge - PAYS, Laurent - WISZTORSKI, Maxence - ČÍŽKOVÁ, Dáša - FOURNIER, Isabelle - SALZET, Michel. Paclitaxel Treatment and Proprotein Convertase 1/3 (PC1/3) Knockdown in Macrophages is a Promising Antiglioma Strategy as Revealed by Proteomics and Cytotoxicity Studies : [Liečba paklitaxelom a vylučovanie PC1/3 v makrofágoch je sľubnou stratégiou antigliómu, ako sa ukázalo v štúdiách proteomiky a cytotoxicity] In: Molecular and Cellular Proteomics. 2018. ISSN 1535-9476, Vol. 17, č. 6(2018), s. 1126-1143.
(2018: 4.828 - IF, 181 - H-index, 5.914 - IF 5y, 2.807 - SJR, Q1 - SJR Best Q, Q1 - JCR Best Q)

Rok vydania:

2018

Kategória:

ADC - Vedecké práce v zahraničných karentovaných časopisoch

Autori:

DUHAMEL Marie

35 %

ROSE Mélanie

5 %

RODET Franck

5 %

MURGOCI Adriana - Natalia

5 %

ZOGRAFIDOU Lea

5 %

RÉGNIER-VIGOUROUX Anne

5 %

VANDEN ABEELE Fabien

5 %

KOBEISSY Firas

5 %

NATAF Serge

5 %

PAYS Laurent

5 %

WISZTORSKI Maxence

5 %

ČÍŽKOVÁ Dáša

5 %

FOURNIER Isabelle

5 %

SALZET Michel

5 %

Podiel UVLF:

5 %

Vydanie:

Molecular and Cellular Proteomics

Vol. 17, č. 6(2018), s. 1126-1143

Krajina vydania:

Slovensko

ISSN:

1535-9476

Oblasť výskumu:

130 - Vedy o živej prírode

Scientometria:

2018: 4.828 - IF, 181 - H-index, 5.914 - IF 5y, 2.807 - SJR, Q1 - SJR Best Q, Q1 - JCR Best Q

Jazyk:

anglický

Ohlasy:

2023-2023: [1] WENG, D.F. - HE, L. - CHEN, X.N. - LIN, H.F. - JI, D.H. - LU, S.T. - AO, L. - WANG, S.L. Integrated analysis of transcription factor-mRNA-miRNA regulatory network related to immune characteristics in medullary thyroid carcinoma. In FRONTIERS IN IMMUNOLOGY. ISSN 1664-3224, 2023, vol. 13, art. no. 1055412.

2022-2022: [1] LU, Jianglong - XU, Fanjie - RAO, Changjun - SHEN, Chaodong - JIN, Jinghao - ZHU, Zhangzhang - WANG, Chengde - LI, Qun. Mechanism of action of paclitaxel for treating glioblastoma based on single-cell RNA sequencing data and network pharmacology. In FRONTIERS IN PHARMACOLOGY, 2022, vol. 13, no., pp. Dostupné na: https://doi.org/10.3389/fphar.2022.1076958.

2019-2019: [1] LARIONOVA, Irina - CHERDYNTSEVA, Nadezhda - LIU, Tengfei - PATYSHEVA, Marina - RAKINA, Militsa - KZHYSHKOWSKA, Julia. Interaction of tumor-associated macrophages and cancer chemotherapy. In ONCOIMMUNOLOGY. ISSN 2162-402X, 2019, vol. 8, no. 7, pp.

2019-2019: [1] LI, Guoxiong - HUANG, Min - CAI, Yingqian - YANG, Yuantao - SUN, Xinlin - KE, Yiquan. Circ-U2AF1 promotes human glioma via derepressing neuro-oncological ventral antigen 2 by sponging hsa-miR-7-5p. In JOURNAL OF CELLULAR PHYSIOLOGY. ISSN 0021-9541, 2019, vol. 234, no. 6, pp. 9144-9155. [WoS]